Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial...

por Fernandez-Plana, Julen, Pericay, Carlos, Quintero, Guillermo, Alonso, Vicente, Salud, Antonieta, Mendez, Miguel, Salgado, Mercedes, Saigi, Eugeni, Cirera, Luis
Publicado 2014

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients ac...

por Páez, David, Tobeña, María, Fernández-Plana, Julen, Sebio, Ana, Virgili, Anna C., Cirera, Lluís, Barnadas, Agustí, Riera, Pau, Sullivan, Ivana, Salazar, Juliana
Publicado 2018

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

por Molla, Meritxell, Fernandez-Plana, Julen, Albiol, Santiago, Fondevila, Constantino, Vollmer, Ivan, Cases, Carla, Garcia-Criado, Angeles, Capdevila, Jaume, Conill, Carles, Fundora, Yliam, Fernandez-Martos, Carlos, Pineda, Estela
Publicado 2021

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

por Alonso, Vicente, Escudero, Pilar, Fernández-Martos, Carlos, Salud, Antonia, Méndez, Miguel, Gallego, Javier, Rodriguez, Jose-R., Martín-Richard, Marta, Fernández-Plana, Julen, Manzano, Hermini, Méndez, José-Carlos, Zanui, Monserrat, Falcó, Esther, Gil-Raga, Mireia, Rojo, Federico, Cuatrecasas, Miriam, Feliu, Jaime, García-Albéniz, Xabier, Maurel, Joan
Publicado 2018

Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)

por García‐Albéniz, Xabier, Alonso, Vicente, Escudero, Pilar, Méndez, Miguel, Gallego, Javier, Rodríguez, Jose Ramon, Salud, Antonia, Fernández‐Plana, Julen, Manzano, Hermini, Zanui, Montserrat, Falcó, Ester, Feliu, Jaime, Gil, Mireia, Fernández‐Martos, Carlos, Bohn, Uriel, Alonso, Carmen, Calderero, Verónica, Rojo, Federico, Cuatrecasas, Miriam, Maurel, Joan
Publicado 2019

Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting

por Romeo, Margarita, Gil-Martín, Marta, Gaba, Lydia, Teruel, Iris, Taus, Álvaro, Fina, Claudia, Masvidal, Maria, Murata, Paola, Fernández-Plana, Julen, Martínez, Alejandro, Pérez, Cristina, García, Yolanda, Rodriguez, Valerie, Cros, Sara, Parera, Marta, Zanui, Montserrat, Catot, Silvia, Pardo, Beatriz, Plaja, Andrea, Esteve, Anna, Barretina-Ginesta, Maria Pilar
Publicado 2022